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I will begin with some brief definitions that I find useful when talking about
biotechnology. I restrict biotechnology to mean techniques involving the use of
molecular biology of DNA. These techniques facilitate two related but different
applications: the extremely specific identification of the DNA in a biological
organism, and the transfer and biological functioning of DNA from one
organism to another. The first has led to the ability to detect the presence or
absence of genes in plants and animals using techniques collectively called
molecular markers. The second has led to the ability to transfer genes from one
organism to another, that is, transformation. These two abilities generate both
the promises and the pitfalls of biotechnology.
This paper considers how these biotechnology abilities may be applied to
plants. Four broad goals have been pursued relative to plants: to change
product characteristics like storability or taste, to incorporate resistance to
insects, diseases, or agrichemicals such as herbicides, to increase innate yield
potential, and to enable plants to produce products they were heretofore
incapable of producing. In turn, a number of promises have been identified,
including the following:
• The potential to raise agricultural productivity and thereby the hope
that we will be better able to feed the world.
• An increase in agricultural research investment.
• A reduction in pesticide use in agriculture, a more sustainable
agricultural system, and other environmental benefits.
• The use of genes from new sources.
• The production of pharmaceuticals from plants.
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For each of the promises, however, one can identify potential pitfalls, and the
following can be enumerated:
• Are we focusing attention on the genes that will give the traits that
will increase productivity?
• Are we paying enough attention to the problems that will have to be
solved to feed the word?
• Will the property rights that accompany the increased investment
mean that the benefits are inappropriately concentrated?
• Will the technology lead to an increase in the intensity of pesticide
use rather than a reduction?
• How will biotechnology contribute to sustainable agriculture?
• Is it really practical to produce pharmaceuticals using plants?
INCREASE PRODUCTIVITY
The promise that plant biotechnology may raise innate productivity rests largely
on the belief that because it opens so many possible ways of changing the
genetics of plants there must be a way to apply that knowledge to increase
productivity. Photosynthesis, the basic process by which plants use the sun’s
energy, water, nutrients, and carbon dioxide, is known to use only a small
fraction, less than 10 percent, of the sun’s energy. It stands to reason that there
may be a way to increase that proportion and thereby increase innate
productivity, but to date no generally accepted means for doing so has been
found.
Likewise, making plants more drought-resistant, or able to better use
available water, would seem to offer great opportunities to increase productivity.
But little progress has been made in achieving greater drought resistance, and
little of the energy of biotechnology is directed toward this goal. Incorporating
into cereal crops the capacity to fix nitrogen biologically is another approach
that would seem to increase productivity, but again, progress has been slow.
More positively, biotechnologists have developed new approaches to creating
hybrid crops, opening the possibility of hybrid wheat and hybrid rice, as well as
other hybrids. As these strategies are proven they likely will lead to higher
yields. There are also other traits that may lead to increased yields — one that
increases the starch content of potato, and another that keeps sorghum leaves
green for a longer period of time than normal, extending the period of grain
filling and thereby promising higher yields.
FEED THE WORLD
The challenge of feeding the world is reflected most dramatically in the
observation that per capita food production in Sub-Saharan Africa has fallen by
20 percent over the past 30 years, leaving that region in desperate need of
additional food production. Furthermore, that area faces the challenge of the
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most rapid rate of population growth of any region. Over the past 30 years, per
capita food production increased in most countries outside Africa, especially in
Asia. There the challenge remains high, driven by rapid growth of per person
income.
An acceptable long-term solution to feeding the world requires most
countries to have a reasonable degree of food self-reliance, meaning that
countries either produce their own food or produce and export something else
with which to purchase food. For largely rural countries, the alternatives to
food are most often other agricultural products. Hence it is reasonable to ask to
what extent biotechnology is being used to address the agricultural needs of the
developing world.
For the results of biotechnology to be applied in a specific place, the plants
incorporating those results will have to be field tested, and seeds incorporating
the traits will have to be multiplied and distributed to farmers. Data on field
tests indicate, therefore, the prospects for contributions from biotechnology in
the next few years.
Clive James and Anatole Krattiger from the International Service for Applied
Agricultural AgroBiotechnology (ISAAA) have tabulated the data on field trials
of genetically engineered crops. Some 3,700 trials have been conducted through
the end of 1995. About 40 percent of those trials have been of crops that have
been transformed to be herbicide resistant. About 22 percent were of crops
transformed for insect resistance or product quality, and another 15 percent or
so of crops were transformed to be resistant to fungal or virus diseases. Some
555, another 15 percent, have been crops transformed with other traits. Except
for this last category, which includes a few tests each on a wide variety of traits,
none of the field trials to date have been directed specifically at increasing
productivity. Of course, it is likely that some increase in yield will be observed
in plants that are pest resistant, but the direct objective is quite different,
supporting the observation that limited resources are directed at increasing
productivity.
Some of the traits that may be most needed in the developing world, in
addition to productivity increases, include the ability to tolerate low soil
fertility, the ability to tolerate soil salinity or alkalinity, the ability to reproduce
apomictically, and techniques for producing biological pesticides. In addition,
molecular markers for these and other desirable traits would contribute to
advances in the genetic improvement of crops through plant breeding.
Application of biotechnology to address the needs of the developing world
requires that it be applied to crops of interest to the developing world. James
and Krattinger show the distribution of field tests among crops. Almost 30
percent of all field trials have been conducted on maize, a crop of importance in
the developing world, especially in Africa. But, the other crops that have been
the focus of attention — tomato, canola, cotton, tobacco, potato — are of little
or no food significance in developing countries.
Maize yields in developing countries may be affected by biotechnology if
genes useful in tropical countries are discovered in the course of the massive
work being done on maize in the United States. Although most of the work on
maize is being done by private firms, some of the discoveries may be made
available for application in developing countries, either at no cost or at low
enough cost as to make their use commercially feasible. Biotechnology
applications on cassava are further in the future, as are those on smallholder
banana and other crops of importance in the developing world.
It is unlikely that the balance of work between the industrialized and
developing worlds will change soon because only a small amount of the
estimated $2.5 billion of research spending on agricultural biotechnology
around the globe is carried out in the developing world. The best available
estimates suggest that between $50 and $75 million per year is spent on
agricultural biotechnology in the developing world, about half of that by the
Consultative Group for International Agricultural Research (CGIAR) Centers.
The rest is divided among private research (multinational and local) and
government-supported research.
A functioning global agricultural research system — the CGIAR — exists, but
over the past five years the financial support for that system has weakened, in
no small part because of falling support by the United States. Whereas in 1992
the United States was the single largest donor, providing $48.1 million to that
system, in 1996 that figure fell to $30.5 million, even though the system is
acknowledged to be one of the most effective uses of foreign assistance to
which the United States contributes.
The CGIAR, which is extremely effective at research that can be shared across
countries, can be complemented by efforts that enable countries to adapt the
research findings to their particular situations. There is still a great need to
improve the national capacity for agricultural research and management in
developing countries, especially in Africa.
I know of five coherent, coordinated programs directed specifically at
enhancing biotechnology research on developing-country crops: one supported
by the United States Agency for International Development (USAID), one by
the Dutch government, one by the McKnight Foundation, one by the
Rockefeller Foundation, and one by the Asian Development Bank.
The USAID-supported project on Agricultural Biotechnology for Sustainable
Productivity (ABSP), headquartered at Michigan State University, was
implemented by a consortium of U.S. universities and private companies. It is
targeted at five crop/pest complexes: potato/potato tuber moth, sweet potato/
sweet potato weevil, maize/stem borer, tomato/tomato yellow leaf virus, and
cucurbits/several viruses. An outgrowth of the earlier USAID-supported tissue
culture for crops project, ABSP builds on the network of scientists associated
with that project.
The cassava biotechnology network, sponsored by the Netherlands
Directorate General for International Cooperation, held its first meeting in
August 1992. It aims to bring the tools of biotechnology to modify cassava so as
to better meet the needs of small-scale cassava producers, processors, and
consumers. More than 125 scientists from 28 countries participated in the first
network meeting. Funding to date has been about $2 million. An important
initial activity is a study of farmers’ needs for technical change in cassava, based
on a field survey of cassava producers in several locations in Africa. Funding
beyond 1997 is not assured.
The Rockefeller Foundation’s support for rice biotechnology in the
developing world started in 1984. The program has two objectives: to create
biotechnology applicable to rice and produce improved rice varieties suited to
developing-country needs; and to ensure that developing-country scientists
know how to use biotechnology techniques and are capable of adapting them to
their own objectives. Approximately $70 million in grants have been made by
the program through 1996. A network of about 200 senior scientists and 300
trainee scientists are participating, in all the major rice-producing countries of
Asia, as well as several industrialized countries. Researchers in the network
transformed rice in 1988, a first for any cereal. Transformed rice has been field
tested in the United States, and a significant number of lines transformed with
agronomically useful traits now exist. Molecular maps are being used to assist
breeding, and some rice varieties developed by advanced techniques not
requiring genetic engineering are now being grown by Chinese farmers.
The McKnight Foundation has provided about $12 million for biotechnology
research on agriculturally important problems to teams of researchers from
advanced and developing-country labs. This innovative program used a global
call for proposals and competitive process to award the grants across a range of
subject matter of interest to the investigators. The research under the first set of
grants is currently under way, but no plans have been announced for further
funding.
The Asian Development Bank provides about $300,000 annually to fund the
Asian Rice Biotechnology Network that links the International Rice Research
Institute (IRRI) and Asian countries so they can share information and
cooperate in the development of tools of biotechnology for rice.
It is unlikely that these five focused crop biotechnology efforts, taken
together, entail in excess of $35 million annually, or about one-half of total
agricultural biotechnology research spending in the developing world, which is
likely between $50 and $75 million annually. China, India, Egypt, Brazil, and a
few other countries have a reasonable base for plant biotechnology.
It is evident that the efforts directed at biotechnology for developing-country
agriculture are small, especially when compared to those directed at the
industrialized world. Still, some important contributions should come from the
former. Training of developing-country scientists under various programs
provides a small cadre of plant molecular biologists in developing countries.
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The Rockefeller Foundation’s support of rice biotechnology is beginning to
pay off in the form of new rice varieties available to some Asian farmers. In
China, a rice variety produced at the Shanghai Academy of Agricultural
Sciences through anther culture and which incorporates genes for resistance to
pathogens and cold has been field tested on over 3,000 hectares in Anhui and
Hubei provinces, resulting in yields from six to 24 percent higher than the most
popular previous varieties.
Rices with several different genes for resistance to two major rice diseases,
blast and bacterial blight, have been produced using genetic markers. These are
being field tested for the durability of their resistance, which is expected to be
high. In addition, dozens of genetically engineered rices are being evaluated in
facilities in Asia. We expect that the contributions to rice yield increases from
biotechnology in Asia will be on the order of 10 to 25 percent over the next ten
years. These increaseswill come from improved hybrid rice systems, largely in
China, and in other Asian countries from rice varieties transformed with genes
for resistance to pests and diseases.
The speed with which varieties get into farmers’ hands depends largely on
national conditions — the closeness of linkages between biotechnologists and
plant breeders; the ability of scientists to identify the most limiting conditions,
identify genes that overcome those constraints, and get those genes into good
agronomic backgrounds; and the efforts plant scientists and others have put
into crafting biosafety regulations.
INCREASE RESEARCH
The advent of biotechnology has stimulated agricultural biotechnology
research. It has certainly encouraged a significant increase in private corporate
research. The potential pitfall associated with this increase is the intellectual
property rights conditions that go along with private research. Some observers
believe that the cost of seeds may be higher than it would be if the research
were done by the public sector, although there is a question of whether the
same results would be forthcoming from the public sector. It is clear that the
fact that property rights can be enforced, because of the capability to very
closely identify biological organisms and their components, has stimulated
great inventive efforts. But some voices question the appropriateness of
property rights associated with nature.
REDUCE PESTICIDES
The potential of biotechnology to reduce pesticide use has been one of the
major points stressed by its supporters. Genes for resistance to insects and plant
viruses are projected to replace the use of pesticides by farmers. The first broad-
scale commercial production of crops with Bacillus thuringensis, the first of such
genes, was conducted in 1996. Many other such genes are being tested,
supporting the idea that biotechnology will lead to a reduction in the use of
pesticides.
Critics of biotechnology point out that herbicide-resistant genes encourage
farmers to use more of those chemicals than they might otherwise, shifting the
balance in the other direction. In addition, there is concern by “organic”
farmers who apply Bt directly to crops that its widespread introduction into
genetically engineered crops will put so much pressure on pests that insects
resistant to Bt will be created, thereby eliminating the usefulness of that
relatively benign pesticide.
SUSTAINABLE AGRICULTURE
The idea that biotechnology will hasten the age of sustainable agriculture has
been promoted by some. But the concept of sustainable agriculture has been
defined in so many different ways by so many different people that it is difficult
to determine what would have to happen to make agriculture sustainable and
whether biotechnology will help bring it about.
NEW GENE SOURCES
There is little doubt that genetic engineering will make new sources of genes
available for use in plants. The genes that code for the Bt toxin come from
bacteria, the genes that code for the coat protein of viruses have been inserted
into plants to make them resistant to the virus, genes that enable cowpeas to
have natural resistance to insects have been inserted into cereal crops, and so
on. This transgenic capability is one of the characteristics that have generated
the excitement about biotechnology. But this capability also generates
unexpected consequences, mainly apprehension about the technology.
Some people’s opposition to genetic engineering is based on ethical grounds:
they believe that transferring genes across species is too close to the act of
creation and therefore not something people should do. Others oppose genetic
engineering because of the unknown possibilities that may result — of new
viruses emerging from transformed plants, or of proteins that cause allergic
reactions being unknowingly transferred into plants. And while those who have
examined the scientific information about the probabilities of such events
indicate they are small, apprehension remains because the probabilities are not
zero. Still others oppose biotechnology because it has led to the patenting of
genes, a practice they oppose on the grounds that genes are not inventions but
rather parts of nature.
A significant number of people have expressed the fear that genetically
engineered crops may not be safe. In the United States, those responsible for
ensuring that the food supply is safe base judgments about food safety of
genetically engineered crops on consideration of the nature of genes that have
been inserted and the nature of the plants into which they have been inserted. If
no evidence of danger exists and no reasonable argument for danger can be
made, products can be grown and consumed. As of the middle of 1997, 20
genetically engineered crops have been approved for general commercial
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production without restriction. The regulatory bodies have found no evidence
of any danger associated with their production or consumption.
The apprehension that food made from genetically engineered crops may not
be safe is strong in some European countries. Surveys show that as much as 60
percent of people in some countries believe genetically engineered crops may
not be safe, while in the United States only 21 percent hold that belief.
Fears have led some to demand that genetically engineered crops or foods
made from such crops should be labeled. In the United States there is not
strong support for the idea, but in some European countries there is
considerable support.
SUMMARY
Plant biotechnology promises many advantages. It may significantly improve
the productivity of agriculture, help feed people in developing countries, reduce
the use of pesticides, and lead to a more sustainable agricultural system. Some
people question each of these promises, but the balance of scientific opinion
holds that the potential dangers associated with genetically engineered crops is
small, especially compared to the potential benefits for regions of the world that
will require considerably increased production over the coming years.
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